Molecular AssaysqPCRCE-IVD

Leukemia Fusion Genes (Q51) Screening Kit

By Zeesan Biotech (致善生物)

Product TypeAssay Kit
TechnologyqPCR
Regulatory StatusCE-IVD
Sample TypesWhole Blood
Leukemia Fusion Genes (Q51) Screening Kit — Zeesan Biotech (致善生物) product image

Key takeaways

Leukemia Fusion Genes (Q51) Screening Kit is a product in the Molecular Assays category, manufactured by Zeesan Biotech (致善生物). Listed regulatory status: CE-IVD (as reported by the manufacturer).

  • Platform: qPCR
  • Sample types: whole blood

Classification

Category
Molecular Assays
Product Type
Assay Kit
Technology
qPCR

Workflow

Sample Types
Whole Blood

Regulatory Status

CE-IVD

Reported from manufacturer sources and not independently verified.

From the manufacturer

Quoted verbatim from the manufacturer’s published product page. IVDmap did not write or verify this text.

  • Leukemia Fusion Genes (Q51) Screening Kit is a multiplex RT-qPCR based assay for detection of the 52 leukemia-associated genes transcripts including EVI1, HOX11, HOX11L2 and 49 fusion genes in total RNA from bone marrow or whole blood samples.
    Zeesan Biotech (致善生物)Product TypeManufacturer Page2026-10-31
  • The kit detects RNA transcripts of the 52 leukemia-associated genes extracted from human bone marrow or whole blood samples using a RT-qPCR procedure.
    Zeesan Biotech (致善生物)Sample TypesManufacturer Page2026-10-31

Review and references

Source

Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.

Published

2026-10-17

Updated

2026-10-31

Disclaimer

availability varies

Explore more